Gabriel Ichim

Université Claude Bernard Lyon 1 — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index3.1kcitations77works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell death mechanisms and regulation(36), Mitochondrial Function and Pathology(11), RNA Interference and Gene Delivery(10), RNA modifications and cancer(8), interferon and immune responses(8)

Publications77 total

Reversing coma by senolytics and stem cells: the future is now
Journal of Translational Medicine·2025· 2 citedOpen Access
Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity
Cell Death and Disease·2025Open Access
Discovery of KDX1381, a Bivalent CK2α Inhibitor for the Treatment of Solid Tumors as a Single Agent or in Combination
Journal of Medicinal Chemistry·2025· 3 cited
OA02.01 Selective Translation of PBK (PDZ-Binding Kinase) is a Novel Mechanism of Drug Tolerance to Targeted Therapies in EGFR-Mutant Lung Cancer
Journal of Thoracic Oncology·2025
Kremen1 dependence receptor induces SEC24C and ATG9A-dependent autophagic cell death
2025Open Access
Author Reply to Peer Reviews of Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity
2024
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors
JHEP Reports·2024· 5 citedOpen Access
Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity
2024· 1 citedOpen Access
Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis
Science Signaling·2024· 9 citedOpen Access
Abstract 1221: Selective translational activation of PBK (PDZ- binding kinase) reveals a molecular vulnerability of drug-tolerant persister cells to targeted therapies in <i>EGFR</i>-mutant lung adenocarcinoma
Cancer Research·2024
Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment
Scientific Reports·2024Open Access
Actualités en recherche en oncologie : l’essentiel du cinquième Symposium International 2022 du Centre de recherche en cancérologie de Lyon
Bulletin du Cancer·2023
Lysosomal MLKL is balanced by ESCRT to control cell death
2023· 1 citedOpen Access
An optogenetic approach to control and monitor inflammasome activation
2023· 2 citedOpen Access
The stress sensor <scp>GCN2</scp> differentially controls ribosome biogenesis in colon cancer according to the nutritional context
Molecular Oncology·2023· 14 citedOpen Access
Shedding light on mitochondrial outer-membrane permeabilization and membrane potential: State of the art methods and biosensors
Seminars in Cell and Developmental Biology·2023· 31 citedOpen Access
Author response for "The stress sensor &lt;scp&gt;GCN2&lt;/scp&gt; differentially controls ribosome biogenesis in colon cancer according to the nutritional context"
2023
Author response for "The stress sensor &lt;scp&gt;GCN2&lt;/scp&gt; differentially controls ribosome biogenesis in colon cancer according to the nutritional context"
2023
Supplementary Data from Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced Apoptosis
2023Open Access
Data from Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced Apoptosis
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Stephen W. G. Tait(15), Kévin Berthenet(8), Patrick Mehlen(8), Héctor Hernández‐Vargas(7), Servane Tauszig-Delamasure(6), Andrew Oberst(5), Catherine Cloix(5), Nikolay Popgeorgiev(5), Joel S. Riley(4), Karen Blyth(4), Deborah Fanfone(4), David Neves(4), Benjamin Gibert(4), Yassmin Elmasry(4), Kirsteen J. Campbell(4), Marco A. M. Prado(4), Jonathan Lopez(3), Evangelos Giampazolias(3), Anthony J. Chalmers(3), Douglas R. Green(3)